X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15721) 15721
Patent (7495) 7495
Conference Proceeding (352) 352
Publication (276) 276
Dissertation (60) 60
Newspaper Article (35) 35
Book Chapter (27) 27
Book Review (13) 13
Magazine Article (13) 13
Book / eBook (8) 8
Technical Report (3) 3
Data Set (2) 2
Paper (2) 2
Journal / eJournal (1) 1
Streaming Audio (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (3317) 3317
index medicus (2593) 2593
physics (2400) 2400
humans (2380) 2380
chemistry (2085) 2085
metallurgy (1948) 1948
basic electric elements (1925) 1925
female (1638) 1638
human necessities (1553) 1553
male (1533) 1533
semiconductor devices (1260) 1260
electric solid state devices not otherwise provided for (1253) 1253
middle aged (1209) 1209
hygiene (1202) 1202
electric communication technique (1198) 1198
medical or veterinary science (1198) 1198
counting (1043) 1043
calculating (1042) 1042
computing (1042) 1042
adult (1017) 1017
preparations for medical, dental, or toilet purposes (1010) 1010
organic chemistry (890) 890
aged (878) 878
animals (854) 854
electric digital data processing (825) 825
performing operations (764) 764
transporting (764) 764
general tagging of cross-sectional technologies spanning over several sections of the ipc (702) 702
general tagging of new technological developments (702) 702
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (702) 702
analysis (658) 658
oncology (612) 612
heterocyclic compounds (550) 550
microbiology (540) 540
cancer (528) 528
pictorial communication, e.g. television (523) 523
original (491) 491
specific therapeutic activity of chemical compounds ormedicinal preparations (491) 491
original article (470) 470
technologies or applications for mitigation or adaptation againstclimate change (461) 461
transmission of digital information, e.g. telegraphiccommunication (461) 461
mice (459) 459
testing (459) 459
measuring (448) 448
biochemistry (431) 431
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (427) 427
optics (426) 426
research (419) 419
expression (410) 410
enzymology (395) 395
wine (394) 394
beer (393) 393
education (393) 393
mutation or genetic engineering (393) 393
spirits (393) 393
vinegar (393) 393
biochemistry & molecular biology (368) 368
surgery (365) 365
retrospective studies (355) 355
mechanical engineering (343) 343
treatment outcome (343) 343
advertising (342) 342
aged, 80 and over (340) 340
display (338) 338
cryptography (337) 337
seals (337) 337
heating (336) 336
lighting (334) 334
blasting (332) 332
weapons (332) 332
foods or foodstuffs (306) 306
their treatment, not covered by other classes (306) 306
pharmacology & pharmacy (304) 304
risk factors (299) 299
prognosis (296) 296
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (293) 293
frequency-changing (293) 293
information storage (293) 293
non-linear optics (293) 293
optical analogue/digital converters (293) 293
optical logic elements (293) 293
techniques or procedures for the operation thereof (293) 293
adhesives (289) 289
dyes (287) 287
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (287) 287
preservation of foods or foodstuffs, in general (287) 287
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (287) 287
miscellaneous applications of materials (282) 282
miscellaneous compositions (282) 282
natural resins (282) 282
paints (282) 282
polishes (282) 282
care and treatment (274) 274
young adult (273) 273
diagnosis (268) 268
compositions based thereon (264) 264
organic macromolecular compounds (264) 264
their preparation or chemical working-up (264) 264
apoptosis (261) 261
culture media (258) 258
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17001) 17001
Korean (9497) 9497
French (1244) 1244
German (640) 640
Chinese (318) 318
Spanish (46) 46
Japanese (44) 44
Portuguese (32) 32
Russian (9) 9
Danish (5) 5
Dutch (4) 4
Polish (4) 4
Hungarian (2) 2
Italian (2) 2
Lithuanian (2) 2
Norwegian (2) 2
Slovenian (2) 2
Croatian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


한국임상수의학회지, ISSN 1598-298X, 06/2016, Volume 33, Issue 3, pp. 168 - 171
Signalment: An 8-month-old female Alaskan malamute was presented for progressive cluster seizure disorder. Results: There were no abnormalities on neurological... 
수의학
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1245 - 1253
Journal Article
Journal Article
Journal for Specialists in Pediatric Nursing, ISSN 1539-0136, 01/2017, Volume 22, Issue 1, p. e12171
Journal Article
Journal of Food Biochemistry, ISSN 0145-8884, 04/2017, Volume 41, Issue 2, p. e12331
Journal Article
Nature Genetics, ISSN 1061-4036, 10/2018, Volume 50, Issue 10, pp. 1399 - 1411
Outcomes of anticancer therapy vary dramatically among patients due to diverse genetic and molecular backgrounds, highlighting extensive intertumoral... 
BREAST-CANCER | MOLECULAR CHARACTERIZATION | GROWTH-FACTOR RECEPTOR | DRUG-SENSITIVITY | PHASE-II TRIAL | GASTRIC-CANCER | DUAL PHOSPHOINOSITIDE-3-KINASE | GENETICS & HEREDITY | KRAS-MUTANT LUNG | TYROSINE KINASES | ERBB FAMILY BLOCKER | Primary Cell Culture - methods | Humans | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Molecular Targeted Therapy | Cell Lineage - drug effects | Feasibility Studies | Neoplasms - genetics | Patient-Centered Care - methods | Antineoplastic Agents - isolation & purification | HEK293 Cells | Gene Expression Regulation, Neoplastic - drug effects | Tumor Cells, Cultured | Antineoplastic Agents - classification | Cell Lineage - genetics | Medical Oncology - methods | Pharmacogenetics - methods | Biomarkers, Pharmacological - analysis | Biomarkers, Tumor - analysis | Neoplasms - drug therapy | Drug Resistance, Neoplasm - genetics | Panobinostat - therapeutic use | Biomarkers, Tumor - genetics | Neoplasms - pathology | Precision Medicine - methods | Drug Screening Assays, Antitumor | Pharmacogenetics | Cancer cells | Research | Cell culture | Therapy | Hematology | Epidermal growth factor receptors | Tumor cells | Brain cancer | Genomics | Oncology | Pharmacology | Genomes | Genetic diversity | Metastasis | Kinases | Gene expression | Patients | Heterogeneity | Molecular modelling | Mutation | Bioinformatics | Artificial intelligence | Cancer | Tumors
Journal Article
Acta Biomaterialia, ISSN 1742-7061, 11/2018, Volume 81, pp. 231 - 241
Journal Article
Gastric Cancer, ISSN 1436-3291, 10/2015, Volume 18, Issue 4, pp. 824 - 832
This multicenter, randomized phase II trial was conducted to compare the efficacy and safety of nimotuzumab plus irinotecan (N-IRI) versus irinotecan alone... 
Irinotecan | Anti-EGFR | Medicine & Public Health | Gastroenterology | Second-line therapy | Abdominal Surgery | Oncology | Cancer Research | Surgical Oncology | Advanced gastric cancer | Nimotuzumab | ADVANCED ESOPHAGOGASTRIC CANCER | MONOCLONAL-ANTIBODY H-R3 | CHEMOTHERAPY PLUS | CELL LUNG-CANCER | CAPECITABINE | GROWTH-FACTOR RECEPTOR | SUPPORTIVE CARE | CISPLATIN | ONCOLOGY | EGFR ANTIBODY | 1ST-LINE THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Antibodies, Monoclonal, Humanized - administration & dosage | DNA Mutational Analysis | Polymerase Chain Reaction | Adult | Camptothecin - administration & dosage | Female | Adenocarcinoma - genetics | Camptothecin - analogs & derivatives | Genes, ras - genetics | Stomach Neoplasms - genetics | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Receptor, Epidermal Growth Factor - biosynthesis | Receptor, ErbB-2 - biosynthesis | Kaplan-Meier Estimate | In Situ Hybridization, Fluorescence | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Stomach Neoplasms - mortality | Salvage Therapy - methods | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Cancer patients | Clinical trials | Product development | Antineoplastic agents | Stomach cancer | Cancer | Original
Journal Article
Journal Article